MedTrace Logo

Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients

NCT03673241 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-09-17

No results posted yet for this study

Summary

This is a non-blinded randomized study that will investigate whether the use of a novel, non-invasive perfusion enhancement system (The Guardian System) impacts motor recovery and hospital length of stay in acute ischemic stroke patients.

Conditions

Interventions

DEVICE

Guardian System

The Study arm will have the Guardian system applied to their bed and recovery chair with the intent for the patient to have the inflatable surface utilized underneath them .

Sponsors & Collaborators

  • TurnCare Inc.

    lead INDUSTRY

Principal Investigators

  • Fern Cudlip, MSN FNP CNRN · Good Samaritan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2019-01-30
Completion
2019-03-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03673241 on ClinicalTrials.gov